Non Operative Treatment for Vaginal Hydrocele.

A randomized controlled trial to assess the efficacy and safety of USG guided aspiration and injection sclerotherapy in patients with vaginal hydrocele. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093710

Enrollment

Registered

2025-08-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N433- Hydrocele, unspecified

Interventions

Intervention1: USG Guided Aspiration and Sclerotherapy: patients will undergo USG guided aspiration of hydrocele liquid and Injection Sclerotherapy (3% Polidocanol 60mg/2ml) average dose 90mg per pati

Eligibility

Inclusion criteria

Inclusion criteria: All Patients with Vaginal Hydrocele between 18 - 7- years

Exclusion criteria

Exclusion criteria: Patients having history of aspiration outside our center Previously operated patient for vaginal hydrocele Patients with pyocele and hematocele Hydrocele with hernia PAtients with CLD and CKD Patients not giving consent for the study

Design outcomes

Primary

Measure	Time frame
To Assess efficacy and safety of USG guided aspiration and injection sclerotherapy as a treatment in patients with vaginal hydroceleTimepoint: 12 months	—

Secondary

Measure	Time frame
Mean Hospital Stay and ComplicationsTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Ram Lakhan Singh Verma

Uttar Pradesh University of Medical SciencesSaifai

ramlakhansinghverma@gmail.com8954890686

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026